safety Archives - Page 5 of 9 -

J&J hopes FDA cardio label will limit Invokana damage

https://pharmaphorum.com/news/jj-hopes-fda-cardio-benefit-label-will-limit-damage-invokana/

Novo’s Tresiba primed for key ‘hypo’ label update in EU

https://pharmaphorum.com/news/novos-tresiba-gets-key-hypo-label-update-eu/

FDA rejects J&J’s sirukumab RA drug

https://pharmaphorum.com/news/fda-rejects-jjs-sirukumab-ra-drug/

AZ talks up Bydureon data, GLP-1 and glucagon combo

https://pharmaphorum.com/news/az-hopes-bydureon-mortality-benefit-stave-off-threat-novo/

FDA puts hold on AZ and Celgene immunotherapy trials

https://pharmaphorum.com/news/fda-puts-hold-az-celgene-immunotherapy-trials/

FDA halts recruitment to three BMS Opdivo trials

https://pharmaphorum.com/news/fda-halts-recruitment-three-bms-opdivo-trials/

Cellectis CAR-T trials on hold after patient death

https://pharmaphorum.com/news/cellectis-car-t-trials-hold-patient-death/

FDA probes blood cancer immunotherapy safety

https://pharmaphorum.com/news/fda-looks-cancer-immunotherapy-blood-cancer-safety/

FDA cracks down on bogus cell therapy firms

https://pharmaphorum.com/news/fda-crack-bogus-cell-therapy-firms/

Search